What is Innovative Eyewear's operating income?

Innovative Eyewear's total operating income in 2025 was -$8.49 million, based on the following breakdown: Total Gross Profit: $567.45 thousand Total Operating Expenses: $9.06 million

Innovative Eyewear (LUCY) Financials

$1.20 +0.51 (+74.73%)

As of 12:24 PM Eastern

Compare

Annual Income Statements for Innovative Eyewear

This table shows Innovative Eyewear's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-3.24	-5.68	-6.66	-7.77	-7.59
Consolidated Net Income / (Loss)	-3.24	-5.68	-6.66	-7.77	-7.59
Net Income / (Loss) Continuing Operations	-3.24	-5.68	-6.66	-7.77	-7.59
Total Pre-Tax Income	-3.24	-5.68	-6.66	-7.92	-8.49
Total Operating Income	-3.21	-5.58	-6.86	-7.92	-8.49
Total Gross Profit	0.15	-0.06	-0.12	0.22	0.57
Total Revenue	0.69	0.66	1.15	1.64	2.66
Operating Revenue	0.69	0.66	1.15	1.64	2.66
Total Cost of Revenue	0.54	0.72	1.27	1.42	2.09
Operating Cost of Revenue	0.54	0.72	1.27	1.42	2.09
Total Operating Expenses	3.35	5.52	6.74	8.14	9.06
Selling, General & Admin Expense	1.39	2.80	3.89	4.47	5.23
Marketing Expense	1.77	2.06	2.05	2.71	2.97
Research & Development Expense	0.09	0.52	0.66	0.82	0.73
Other Operating Expenses / (Income)	0.11	0.14	0.14	0.14	0.14
Total Other Income / (Expense), net	-0.04	-0.11	0.19	0.00	0.00
Other Gains / (Losses), net	-	-	-	0.16	0.90
Basic Earnings per Share	($0.62)	($0.87)	($10.87)	($5.19)	($1.90)
Weighted Average Basic Shares Outstanding	5.25M	6.53M	613K	1.50M	3.99M
Diluted Earnings per Share	($0.62)	($0.87)	($10.87)	($5.19)	($1.90)
Weighted Average Diluted Shares Outstanding	5.25M	6.53M	613K	1.50M	3.99M
Weighted Average Basic & Diluted Shares Outstanding	5.25M	6.53M	12.93M	2.45M	6.30M

This table shows Innovative Eyewear's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-2.39	-1.97	-1.95	-1.72	-2.13	-1.78	-2.11	-1.84	-1.87	-2.31	-1.67
Consolidated Net Income / (Loss)	-2.39	-1.97	-1.95	-1.72	-2.13	-1.78	-2.11	-1.84	-1.87	-2.31	-1.67
Net Income / (Loss) Continuing Operations	-2.39	-1.97	-1.95	-1.72	-2.13	-1.78	-2.11	-1.84	-1.87	-2.31	-1.67
Total Pre-Tax Income	-2.39	-2.01	-1.97	-1.76	-2.17	-1.90	-2.17	-1.92	-2.50	-2.37	-1.70
Total Operating Income	-2.50	-2.01	-1.97	-1.76	-2.17	-1.90	-2.17	-1.92	-2.50	-2.37	-1.70
Total Gross Profit	-0.18	0.01	0.06	0.06	0.09	0.22	-0.01	0.24	0.11	0.18	0.24
Total Revenue	0.62	0.38	0.31	0.25	0.69	0.45	0.58	0.67	0.96	0.77	1.01
Operating Revenue	0.62	0.38	0.31	0.25	0.69	0.45	0.58	0.67	0.96	0.77	1.01
Total Cost of Revenue	0.80	0.38	0.25	0.19	0.60	0.23	0.59	0.42	0.85	0.60	0.77
Operating Cost of Revenue	0.80	0.38	0.25	0.19	0.60	0.23	0.59	0.42	0.85	0.60	0.77
Total Operating Expenses	2.32	2.02	2.03	1.82	2.27	2.12	2.16	2.17	2.61	2.55	1.95
Selling, General & Admin Expense	1.01	1.11	1.30	1.12	0.95	1.09	1.31	1.28	1.55	1.59	1.22
Marketing Expense	1.15	0.66	0.44	0.53	1.07	0.79	0.54	0.72	0.92	0.78	0.55
Research & Development Expense	0.12	0.22	0.26	0.13	0.21	0.21	0.27	0.13	0.12	0.14	0.14
Other Operating Expenses / (Income)	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
Total Other Income / (Expense), net	0.10	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00
Other Gains / (Losses), net	-	0.04	0.03	0.04	0.05	0.13	0.06	0.08	0.63	0.06	0.03
Basic Earnings per Share	($3.90)	($2.59)	($1.87)	($0.99)	($1.42)	($0.72)	($0.66)	($0.38)	($0.47)	($0.37)	($0.26)
Weighted Average Basic Shares Outstanding	613K	760.35K	1.04M	1.74M	1.50M	2.45M	3.21M	4.87M	3.99M	6.25M	6.41M
Diluted Earnings per Share	($3.90)	($2.59)	($1.87)	($0.99)	($1.42)	($0.72)	($0.66)	($0.38)	($0.47)	($0.37)	($0.26)
Weighted Average Diluted Shares Outstanding	613K	760.35K	1.04M	1.74M	1.50M	2.45M	3.21M	4.87M	3.99M	6.25M	6.41M
Weighted Average Basic & Diluted Shares Outstanding	12.93M	17.50M	1.57M	2.44M	2.45M	3.09M	4.57M	5.35M	6.30M	6.40M	8.61M

This table details how cash moves in and out of Innovative Eyewear's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.05	3.51	0.70	-1.66	3.88
Net Cash From Operating Activities	-1.21	-3.22	-5.77	-6.74	-7.28
Net Cash From Continuing Operating Activities	-1.21	-3.22	-5.77	-6.74	-7.27
Net Income / (Loss) Continuing Operations	-3.24	-5.68	-6.66	-7.77	-7.59
Consolidated Net Income / (Loss)	-3.24	-5.68	-6.66	-7.77	-7.59
Depreciation Expense	0.00	0.02	0.06	0.11	0.07
Amortization Expense	0.01	0.01	0.02	0.13	0.07
Non-Cash Adjustments To Reconcile Net Income	2.20	2.63	1.18	0.98	0.93
Changes in Operating Assets and Liabilities, net	-0.18	-0.21	-0.37	-0.20	-0.75
Net Cash From Investing Activities	-0.12	-0.22	-0.20	-5.16	4.48
Net Cash From Continuing Investing Activities	-0.12	-0.22	-0.20	-5.16	4.48
Purchase of Property, Plant & Equipment	-0.02	-0.12	-0.08	-0.06	-0.07
Purchase of Investments	-	0.00	-1.95	-4.90	-1.27
Sale and/or Maturity of Investments	-	0.00	2.00	0.00	6.30
Other Investing Activities, net	-0.03	-0.06	-0.17	-0.20	-0.48
Net Cash From Financing Activities	1.39	6.96	6.66	10	6.68
Net Cash From Continuing Financing Activities	1.39	6.96	6.66	10	6.68
Repayment of Debt	-0.06	-0.65	-0.60	-0.30	-0.27
Issuance of Debt	1.06	1.48	-	2.87	0.00
Issuance of Common Equity	0.49	6.13	4.12	3.72	1.18
Other Financing Activities, net	-0.11	0.01	3.15	3.95	5.77

This table details how cash moves in and out of Innovative Eyewear's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	0.38	-1.64	3.25	-1.35	-1.91	2.63	2.37	-0.93	-0.19	-2.13	-1.92
Net Cash From Operating Activities	-1.34	-1.47	-1.93	-1.40	-1.94	-2.31	-2.12	-1.50	-1.35	-2.49	-1.86
Net Cash From Continuing Operating Activities	-1.34	-1.47	-1.93	-1.40	-1.94	-2.31	-2.12	-1.50	-1.35	-2.49	-1.85
Net Income / (Loss) Continuing Operations	-2.39	-1.97	-1.95	-1.72	-2.13	-1.78	-2.11	-1.84	-1.87	-2.31	-1.67
Consolidated Net Income / (Loss)	-2.39	-1.97	-1.95	-1.72	-2.13	-1.78	-2.11	-1.84	-1.87	-2.31	-1.67
Depreciation Expense	0.02	0.02	0.04	0.02	0.03	0.02	0.02	0.01	0.01	0.01	0.01
Amortization Expense	0.00	0.01	0.10	0.01	0.01	0.01	0.02	0.01	0.02	0.02	0.02
Non-Cash Adjustments To Reconcile Net Income	0.35	0.59	0.23	0.10	0.07	0.20	0.32	-0.01	0.38	0.00	0.48
Changes in Operating Assets and Liabilities, net	0.68	-0.12	-0.34	0.19	0.08	-0.77	-0.38	0.32	0.11	-0.21	-0.69
Net Cash From Investing Activities	2.01	-0.10	-0.02	-4.99	-0.06	4.94	-1.27	-0.01	0.82	-1.05	-0.03
Net Cash From Continuing Investing Activities	2.01	-0.10	-0.02	-4.99	-0.06	4.94	-1.27	-0.01	0.82	-1.05	-0.03
Purchase of Investments	-	-	-	-4.90	-	0.00	-1.27	-	-	-1.29	-1.28
Sale and/or Maturity of Investments	-	0.00	-	-	-	5.00	-	-	1.30	0.00	1.30
Other Investing Activities, net	-0.02	-0.06	-0.01	-0.09	-0.03	-0.02	-	-	-0.46	0.24	-0.05
Net Cash From Financing Activities	-0.29	-0.08	5.20	5.03	0.09	0.00	5.76	0.58	0.34	1.40	-0.03
Net Cash From Continuing Financing Activities	-0.29	-0.08	5.20	5.03	0.09	0.00	5.76	0.58	0.34	1.40	-0.03
Other Financing Activities, net	-	-0.08	0.08	3.80	0.14	0.00	5.82	-0.04	-0.01	-0.01	0.02

This table presents Innovative Eyewear's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	0.82	4.69	6.22	9.84	10
Total Current Assets	0.64	4.24	5.62	9.24	9.44
Cash & Equivalents	0.08	3.59	4.29	2.63	6.51
Short-Term Investments	-	-	0.00	4.90	0.00
Accounts Receivable	0.04	0.11	0.09	0.11	0.14
Inventories, net	0.34	0.29	0.86	1.26	2.18
Prepaid Expenses	0.07	0.21	0.31	0.27	0.26
Other Current Assets	0.11	0.04	0.07	0.08	0.33
Plant, Property, & Equipment, net	0.02	0.12	0.15	0.11	0.06
Total Noncurrent Assets	0.16	0.33	0.45	0.49	0.64
Intangible Assets	0.16	0.25	0.37	0.45	0.56
Other Noncurrent Operating Assets	0.00	0.08	0.07	0.04	0.08
Total Liabilities & Shareholders' Equity	0.82	4.69	6.22	9.84	10
Total Liabilities	0.62	0.67	0.66	0.74	1.07
Total Current Liabilities	0.62	0.60	0.62	0.74	1.05
Accounts Payable	0.17	0.28	0.58	0.69	0.99
Current Deferred Revenue	0.00	0.03	0.04	0.04	0.06
Other Current Liabilities	0.16	0.23	-	-	0.00
Total Noncurrent Liabilities	0.00	0.07	0.04	0.01	0.03
Noncurrent Deferred Revenue	0.00	0.07	0.04	0.01	0.00
Other Noncurrent Operating Liabilities	-	-	-	0.00	0.03
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	0.21	4.02	5.56	9.10	9.07
Total Preferred & Common Equity	0.21	4.02	5.56	9.10	9.07
Total Common Equity	0.21	4.02	5.56	9.10	9.07
Common Stock	4.84	14	23	34	41
Retained Earnings	-4.62	-10	-17	-25	-32

This table presents Innovative Eyewear's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	8.12	4.81	7.86	12	7.94	12	11	9.48	7.47
Total Current Assets	7.50	4.11	7.29	11	7.33	11	11	8.75	6.79
Cash & Equivalents	3.90	2.65	5.90	4.54	5.26	7.63	6.70	4.38	2.46
Short-Term Investments	1.95	-	-	4.90	0.00	1.29	1.30	1.30	1.29
Accounts Receivable	0.13	0.05	0.06	0.08	0.09	0.06	0.08	0.07	0.14
Inventories, net	1.18	0.92	1.00	1.05	1.51	1.97	2.16	2.10	2.23
Prepaid Expenses	0.29	0.43	0.27	0.32	0.42	0.36	0.31	0.83	0.59
Other Current Assets	0.05	0.06	0.06	0.09	0.05	0.04	0.05	0.07	0.09
Plant, Property, & Equipment, net	0.18	0.14	0.13	0.11	0.13	0.06	0.06	0.05	0.03
Total Noncurrent Assets	0.44	0.56	0.44	0.50	0.49	0.54	0.52	0.68	0.66
Intangible Assets	0.38	0.44	0.35	0.43	0.46	0.44	0.42	0.60	0.63
Other Noncurrent Operating Assets	0.05	0.12	0.09	0.07	0.03	0.11	0.10	0.08	0.03
Total Liabilities & Shareholders' Equity	8.12	4.81	7.86	12	7.94	12	11	9.48	7.47
Total Liabilities	0.47	0.91	0.52	0.67	0.45	0.66	0.93	1.11	0.57
Total Current Liabilities	0.43	0.88	0.49	0.65	0.45	0.61	0.88	1.09	0.56
Accounts Payable	0.19	0.84	0.38	0.61	0.31	0.48	0.77	1.04	0.50
Current Deferred Revenue	0.04	0.04	0.04	0.05	0.08	0.07	0.05	0.01	0.02
Other Current Liabilities	0.20	-	0.08	-	0.05	0.05	0.06	0.03	0.05
Total Noncurrent Liabilities	0.04	0.03	0.02	0.01	0.00	0.05	0.04	0.02	0.01
Noncurrent Deferred Revenue	0.04	0.03	0.02	0.01	0.00	0.00	0.00	-	0.01
Other Noncurrent Operating Liabilities	-	-	-	-	-	0.05	0.04	0.02	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	7.64	3.90	7.34	11	7.49	11	10	8.37	6.90
Total Preferred & Common Equity	7.64	3.90	7.34	11	7.49	11	10	8.37	6.90
Total Common Equity	7.64	3.90	7.34	11	7.49	11	10	8.37	6.90
Common Stock	22	23	28	34	34	40	41	43	43
Retained Earnings	-15	-19	-21	-23	-27	-29	-30	-35	-36

This table displays calculated financial ratios and metrics derived from Innovative Eyewear's official financial filings.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	7,307,157.00	12,917,239.00	2,442,248.00	5,350,183.00
DEI Adjusted Shares Outstanding	0.00	365,358.00	645,862.00	2,442,248.00	5,350,183.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-15.55	-10.32	-3.18	-1.42
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	-4.47%	74.67%	41.99%	62.65%
EBITDA Growth	0.00%	-73.39%	-18.60%	-16.90%	-8.76%
EBIT Growth	0.00%	-73.99%	-19.43%	-18.97%	-7.21%
NOPAT Growth	0.00%	-73.99%	-22.93%	-15.58%	-7.21%
Net Income Growth	0.00%	-75.12%	-17.28%	-16.55%	2.26%
EPS Growth	0.00%	-40.32%	-17.28%	52.25%	63.39%
Operating Cash Flow Growth	0.00%	-165.57%	-78.83%	-16.88%	-7.95%
Free Cash Flow Firm Growth	0.00%	0.00%	-40.04%	-4.85%	-18.55%
Invested Capital Growth	0.00%	18.68%	157.01%	23.56%	62.64%
Revenue Q/Q Growth	0.00%	0.00%	90.87%	4.80%	11.25%
EBITDA Q/Q Growth	0.00%	0.00%	-8.49%	4.28%	-3.03%
EBIT Q/Q Growth	0.00%	0.00%	-8.48%	3.91%	-4.00%
NOPAT Q/Q Growth	0.00%	0.00%	-9.93%	3.91%	-4.00%
Net Income Q/Q Growth	0.00%	0.00%	-8.40%	3.33%	3.26%
EPS Q/Q Growth	0.00%	0.00%	-8.40%	-12.10%	-18.01%
Operating Cash Flow Q/Q Growth	0.00%	-28.44%	-4.03%	-9.81%	7.54%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-6.78%	-6.99%
Invested Capital Q/Q Growth	0.00%	0.00%	-28.95%	5.30%	13.46%
Profitability Metrics	-	-	-	-	-
Gross Margin	21.47%	-8.53%	-10.35%	13.15%	21.32%
EBITDA Margin	-462.94%	-840.28%	-570.52%	-469.69%	-314.07%
Operating Margin	-464.05%	-845.22%	-594.85%	-484.20%	-319.16%
EBIT Margin	-464.05%	-845.22%	-577.92%	-484.20%	-319.16%
Profit (Net Income) Margin	-469.76%	-861.16%	-578.18%	-474.60%	-285.20%
Tax Burden Percent	100.00%	100.00%	100.00%	98.02%	89.36%
Interest Burden Percent	101.23%	101.89%	100.05%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-538.26%	-856.54%	-543.46%	-390.28%	-288.24%
ROIC Less NNEP Spread (ROIC-NNEP)	-1,016.49%	-749.44%	-495.75%	-352.69%	-264.80%
Return on Net Nonoperating Assets (RNNOA)	-1,025.24%	588.02%	404.39%	284.28%	204.64%
Return on Equity (ROE)	-1,563.50%	-268.52%	-139.06%	-106.00%	-83.60%
Cash Return on Invested Capital (CROIC)	0.00%	-873.63%	-631.42%	-411.36%	-335.94%
Operating Return on Assets (OROA)	-388.82%	-202.27%	-122.11%	-98.69%	-85.04%
Return on Assets (ROA)	-393.60%	-206.08%	-122.17%	-96.74%	-75.99%
Return on Common Equity (ROCE)	-1,563.50%	-268.52%	-139.06%	-106.00%	-83.60%
Return on Equity Simple (ROE_SIMPLE)	-1,563.50%	-141.18%	-119.87%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.24	-3.90	-4.80	-5.55	-5.95
NOPAT Margin	-324.84%	-591.65%	-416.40%	-338.94%	-223.41%
Net Nonoperating Expense Percent (NNEP)	478.23%	-107.10%	-47.70%	-37.59%	-23.44%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-86.33%	-60.98%	-65.59%
Cost of Revenue to Revenue	78.53%	108.53%	110.35%	86.85%	78.68%
SG&A Expenses to Revenue	200.69%	423.87%	337.27%	273.36%	196.34%
R&D to Revenue	12.49%	79.52%	57.46%	50.07%	27.25%
Operating Expenses to Revenue	485.52%	836.69%	584.50%	497.35%	340.48%
Earnings before Interest and Taxes (EBIT)	-3.21	-5.58	-6.66	-7.92	-8.49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.20	-5.54	-6.58	-7.69	-8.36
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	35.42	2.49	0.98	1.32	0.59
Price to Tangible Book Value (P/TBV)	153.73	2.65	1.05	1.39	0.63
Price to Revenue (P/Rev)	10.64	15.17	4.73	7.34	2.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	18.14	13.10	0.91	2.86	0.00
Enterprise Value to Revenue (EV/Rev)	10.94	9.82	1.01	2.74	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	1.39	0.02	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	1.01	-0.78	-0.82	-0.81	-0.77
Leverage Ratio	3.97	1.30	1.14	1.10	1.10
Compound Leverage Factor	4.02	1.33	1.14	1.10	1.10
Debt to Total Capital	58.21%	1.50%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	58.21%	1.50%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	41.79%	98.50%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.09	-0.01	0.00	0.00	0.00
Net Debt to EBITDA	-0.07	0.64	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.13	-0.02	0.00	0.00	0.00
Net Debt to NOPAT	-0.09	0.90	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-12.66	3.10	-1.25	4.73	-2.99
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	1.04	7.07	8.99	12.52	9.03
Quick Ratio	0.20	6.17	7.01	10.35	6.36
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3.98	-5.58	-5.85	-6.93
Operating Cash Flow to CapEx	-5,842.36%	-2,652.51%	-7,536.37%	-10,834.90%	-10,033.10%
Free Cash Flow to Firm to Interest Expense	0.00	-37.86	-1,836.49	0.00	0.00
Operating Cash Flow to Interest Expense	-30.79	-30.66	-1,899.31	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-31.32	-31.81	-1,924.51	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.84	0.24	0.21	0.20	0.27
Accounts Receivable Turnover	15.92	8.59	11.33	16.27	21.29
Inventory Turnover	1.59	2.26	2.21	1.35	1.22
Fixed Asset Turnover	34.05	9.42	8.39	12.47	31.44
Accounts Payable Turnover	3.25	3.24	2.97	2.23	2.50
Days Sales Outstanding (DSO)	22.93	42.50	32.22	22.43	17.15
Days Inventory Outstanding (DIO)	228.94	161.24	164.91	271.34	299.77
Days Payable Outstanding (DPO)	112.41	112.83	123.07	163.70	146.25
Cash Conversion Cycle (CCC)	139.46	90.91	74.06	130.08	170.67
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.42	0.49	1.27	1.57	2.56
Invested Capital Turnover	1.66	1.45	1.31	1.15	1.29
Increase / (Decrease) in Invested Capital	0.00	0.08	0.78	0.30	0.98
Enterprise Value (EV)	7.56	6.48	1.16	4.49	-1.18
Market Capitalization	7.35	10	5.45	12	5.33
Book Value per Share	$0.04	$0.55	$0.43	$3.72	$1.69
Tangible Book Value per Share	$0.01	$0.52	$0.40	$3.54	$1.59
Total Capital	0.50	4.09	5.56	9.10	9.07
Total Debt	0.29	0.06	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	0.21	-3.53	-4.29	-7.52	-6.51
Capital Expenditures (CapEx)	0.02	0.12	0.08	0.06	0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.24	0.11	0.70	0.98	1.88
Debt-free Net Working Capital (DFNWC)	0.32	3.70	4.99	8.50	8.39
Net Working Capital (NWC)	0.03	3.64	4.99	8.50	8.39
Net Nonoperating Expense (NNE)	1.00	1.78	1.86	2.22	1.64
Net Nonoperating Obligations (NNO)	0.21	-3.53	-4.29	-7.52	-6.51
Total Depreciation and Amortization (D&A)	0.01	0.03	0.09	0.24	0.14
Debt-free, Cash-free Net Working Capital to Revenue	34.29%	16.82%	61.16%	59.66%	70.59%
Debt-free Net Working Capital to Revenue	45.83%	561.10%	433.18%	519.45%	315.21%
Net Working Capital to Revenue	3.99%	551.80%	433.18%	519.45%	315.21%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($17.40)	($12.60)	($5.19)	($1.90)
Adjusted Weighted Average Basic Shares Outstanding	0.00	385.79K	646.68K	1.50M	3.99M
Adjusted Diluted Earnings per Share	$0.00	($17.40)	($12.60)	($5.19)	($1.90)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	385.79K	646.68K	1.50M	3.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	($17.40)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	326.45K	646.68K	2.45M	6.30M
Normalized Net Operating Profit after Tax (NOPAT)	-2.24	-3.90	-4.80	-5.55	-5.95
Normalized NOPAT Margin	-324.84%	-591.65%	-416.40%	-338.94%	-223.41%
Pre Tax Income Margin	-469.76%	-861.16%	-578.18%	-484.20%	-319.16%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	-81.28	-53.02	-2,193.81	0.00	0.00
NOPAT to Interest Expense	-56.90	-37.12	-1,580.66	0.00	0.00
EBIT Less CapEx to Interest Expense	-81.81	-54.18	-2,219.01	0.00	0.00
NOPAT Less CapEx to Interest Expense	-57.42	-38.27	-1,605.86	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Innovative Eyewear's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	12,917,239.00	12,933,544.00	17,501,066.00	1,570,569.00	2,442,248.00	2,452,632.00	3,094,754.00	4,574,602.00	5,350,183.00	6,300,661.00	6,403,728.00
DEI Adjusted Shares Outstanding	645,862.00	646,677.00	875,053.00	1,570,569.00	2,442,248.00	2,452,632.00	3,094,754.00	4,574,602.00	5,350,183.00	6,300,661.00	6,403,728.00
DEI Earnings Per Adjusted Shares Outstanding	-3.71	-3.05	-2.23	-1.10	-0.87	-0.73	-0.68	-0.40	-0.35	-0.37	-0.26
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	818.10%	164.61%	81.65%	14.30%	12.17%	18.52%	87.65%	163.46%	38.96%	70.20%	74.46%
EBITDA Growth	-27.65%	-40.53%	-46.52%	-12.82%	10.19%	5.80%	-15.79%	-9.50%	-15.65%	-25.28%	21.37%
EBIT Growth	-27.79%	-40.99%	-53.44%	-13.60%	9.23%	5.50%	-9.96%	-9.01%	-15.03%	-24.58%	21.47%
NOPAT Growth	-32.99%	-40.98%	-47.97%	-10.35%	12.94%	5.50%	-9.96%	-9.01%	-15.03%	-24.58%	21.47%
Net Income Growth	-27.52%	-37.78%	-51.30%	-10.93%	11.18%	9.77%	-8.09%	-6.72%	12.04%	-29.83%	20.67%
EPS Growth	-27.52%	-37.78%	-51.30%	52.40%	63.59%	72.20%	64.71%	61.62%	66.90%	48.61%	60.61%
Operating Cash Flow Growth	-19.99%	-7.70%	-11.92%	-4.53%	-44.91%	-57.50%	-9.70%	-6.98%	30.51%	-7.77%	11.93%
Free Cash Flow Firm Growth	0.00%	25.89%	41.65%	56.47%	27.86%	-49.10%	-105.88%	-124.86%	-50.16%	8.82%	18.57%
Invested Capital Growth	157.01%	13.33%	-12.05%	-16.62%	23.56%	79.27%	63.39%	50.95%	62.64%	20.41%	33.45%
Revenue Q/Q Growth	177.52%	-37.72%	-19.50%	-17.84%	172.35%	-34.20%	27.44%	15.35%	43.66%	-19.40%	30.63%
EBITDA Q/Q Growth	-55.00%	16.40%	7.28%	6.10%	-23.39%	12.31%	-13.97%	11.21%	-30.32%	5.01%	28.47%
EBIT Q/Q Growth	-54.32%	15.84%	2.00%	10.75%	-23.30%	12.38%	-14.04%	11.53%	-30.11%	5.10%	28.11%
NOPAT Q/Q Growth	-56.28%	19.27%	2.00%	10.75%	-23.30%	12.38%	-14.04%	11.53%	-30.11%	5.10%	28.11%
Net Income Q/Q Growth	-54.32%	17.65%	1.16%	11.69%	-23.56%	16.34%	-18.41%	12.81%	-1.84%	-23.49%	27.65%
EPS Q/Q Growth	-54.32%	17.65%	1.16%	47.06%	-43.43%	49.30%	8.33%	42.42%	-23.68%	21.28%	29.73%
Operating Cash Flow Q/Q Growth	-0.15%	-9.42%	-31.48%	27.45%	-38.84%	-18.93%	8.42%	29.25%	9.82%	-84.45%	25.16%
Free Cash Flow Firm Q/Q Growth	-17.36%	38.30%	23.97%	20.93%	-94.50%	-27.51%	-4.99%	13.64%	-29.88%	22.57%	6.24%
Invested Capital Q/Q Growth	-28.95%	-1.90%	16.04%	3.09%	5.30%	42.32%	5.76%	-4.76%	13.46%	5.37%	17.21%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-29.26%	1.81%	17.87%	23.40%	13.57%	48.52%	-2.19%	36.65%	11.96%	22.68%	24.00%
EBITDA Margin	-385.62%	-517.67%	-596.25%	-681.47%	-308.74%	-411.42%	-367.94%	-283.23%	-256.94%	-302.84%	-165.83%
Operating Margin	-405.28%	-525.36%	-639.61%	-694.82%	-314.57%	-418.88%	-374.82%	-287.49%	-260.39%	-306.60%	-168.72%
EBIT Margin	-388.74%	-525.36%	-639.61%	-694.82%	-314.57%	-418.88%	-374.82%	-287.49%	-260.39%	-306.60%	-168.72%
Profit (Net Income) Margin	-388.74%	-514.07%	-631.20%	-678.50%	-307.83%	-391.35%	-363.60%	-274.84%	-194.84%	-298.54%	-165.34%
Tax Burden Percent	100.00%	97.85%	98.69%	97.65%	97.86%	93.43%	97.01%	95.60%	74.83%	97.37%	98.00%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-370.26%	-435.80%	-442.93%	-462.91%	-253.55%	-287.48%	-272.30%	-257.21%	-235.17%	-259.63%	-146.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-353.71%	-417.42%	-434.35%	-456.54%	-243.30%	-276.21%	-264.38%	-251.57%	-233.45%	-247.76%	-138.46%
Return on Net Nonoperating Assets (RNNOA)	288.53%	301.47%	351.92%	375.88%	196.11%	191.79%	210.26%	207.10%	180.41%	170.79%	96.41%
Return on Equity (ROE)	-81.73%	-134.33%	-91.02%	-87.03%	-57.44%	-95.70%	-62.04%	-50.11%	-54.76%	-88.84%	-49.59%
Cash Return on Invested Capital (CROIC)	-631.42%	-456.25%	-353.00%	-333.72%	-411.36%	-370.81%	-342.31%	-346.05%	-335.94%	-273.15%	-244.15%
Operating Return on Assets (OROA)	-82.14%	-147.25%	-113.78%	-110.08%	-64.12%	-112.15%	-74.91%	-60.41%	-69.38%	-104.92%	-59.32%
Return on Assets (ROA)	-82.14%	-144.08%	-112.29%	-107.49%	-62.74%	-104.78%	-72.67%	-57.75%	-51.92%	-102.16%	-58.13%
Return on Common Equity (ROCE)	-81.73%	-134.33%	-91.02%	-87.03%	-57.44%	-95.70%	-62.04%	-50.11%	-54.76%	-88.84%	-49.59%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-184.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.75	-1.41	-1.38	-1.23	-1.52	-1.33	-1.52	-1.34	-1.75	-1.66	-1.19
NOPAT Margin	-283.69%	-367.75%	-447.73%	-486.38%	-220.20%	-293.21%	-262.37%	-201.25%	-182.27%	-214.62%	-118.10%
Net Nonoperating Expense Percent (NNEP)	-16.55%	-18.38%	-8.58%	-6.37%	-10.25%	-11.27%	-7.92%	-5.64%	-1.72%	-11.87%	-7.54%
Return On Investment Capital (ROIC_SIMPLE)	-31.42%	-36.14%	-18.82%	-11.28%	-16.72%	-17.78%	-13.48%	-13.12%	-19.30%	-19.84%	-17.30%
Cost of Revenue to Revenue	129.26%	98.19%	82.13%	76.60%	86.43%	51.48%	102.19%	63.35%	88.04%	77.32%	76.00%
SG&A Expenses to Revenue	163.91%	289.19%	419.62%	442.42%	137.12%	240.12%	226.31%	191.18%	161.11%	205.55%	120.59%
R&D to Revenue	19.62%	56.41%	83.19%	51.80%	31.12%	46.33%	46.31%	19.46%	12.15%	17.85%	14.06%
Operating Expenses to Revenue	376.02%	527.17%	657.48%	718.22%	328.14%	467.40%	372.63%	324.14%	272.35%	329.28%	192.72%
Earnings before Interest and Taxes (EBIT)	-2.39	-2.01	-1.97	-1.76	-2.17	-1.90	-2.17	-1.92	-2.50	-2.37	-1.70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2.37	-1.99	-1.84	-1.73	-2.13	-1.87	-2.13	-1.89	-2.47	-2.34	-1.68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.98	0.91	1.18	1.20	1.32	0.85	0.58	0.86	0.59	0.82	0.72
Price to Tangible Book Value (P/TBV)	1.05	1.02	1.24	1.25	1.39	0.91	0.61	0.90	0.63	0.88	0.80
Price to Revenue (P/Rev)	4.73	2.54	5.66	8.40	7.34	3.73	3.32	3.69	2.00	2.30	1.46
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.91	0.71	1.91	2.46	2.86	0.50	0.00	0.37	0.00	0.44	0.40
Enterprise Value to Revenue (EV/Rev)	1.01	0.63	1.81	2.35	2.74	0.66	0.00	0.35	0.00	0.40	0.37
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.82	-0.72	-0.81	-0.82	-0.81	-0.69	-0.80	-0.82	-0.77	-0.69	-0.70
Leverage Ratio	1.14	1.17	1.06	1.06	1.10	1.12	1.06	1.08	1.10	1.10	1.07
Compound Leverage Factor	1.14	1.17	1.06	1.06	1.10	1.12	1.06	1.08	1.10	1.10	1.07
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.01	-3.47	6.77	9.79	6.66	4.34	3.26	2.60	-1.04	-0.95	-0.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.99	4.65	14.73	16.83	12.52	16.39	18.70	11.98	9.03	8.02	12.06
Quick Ratio	7.01	3.06	12.05	14.58	10.35	11.96	14.80	9.14	6.36	5.27	6.89
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-2.52	-1.56	-1.18	-0.94	-1.82	-2.32	-2.44	-2.10	-2.73	-2.12	-1.98
Operating Cash Flow to CapEx	0.00%	-4,543.18%	-55,922.72%	0.00%	-7,345.56%	-5,685.52%	0.00%	-10,093.93%	-7,929.03%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.21	0.28	0.18	0.16	0.20	0.27	0.20	0.21	0.27	0.34	0.35
Accounts Receivable Turnover	11.33	15.42	15.91	14.98	16.27	23.97	33.09	29.13	21.29	36.99	35.11
Inventory Turnover	2.21	1.82	1.55	1.45	1.35	1.05	1.09	1.15	1.22	1.36	1.26
Fixed Asset Turnover	8.39	9.90	11.96	10.95	12.47	12.62	20.93	29.01	31.44	33.64	76.08
Accounts Payable Turnover	2.97	2.67	5.97	4.08	2.23	2.22	3.76	2.68	2.50	3.62	5.37
Days Sales Outstanding (DSO)	32.22	23.67	22.94	24.37	22.43	15.22	11.03	12.53	17.15	9.87	10.40
Days Inventory Outstanding (DIO)	164.91	200.31	236.09	251.49	271.34	346.27	334.81	317.36	299.77	267.84	290.57
Days Payable Outstanding (DPO)	123.07	136.63	61.19	89.43	163.70	164.72	97.03	136.44	146.25	100.71	67.94
Cash Conversion Cycle (CCC)	74.06	87.35	197.84	186.43	130.08	196.78	248.81	193.45	170.67	177.00	233.02
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1.27	1.25	1.45	1.49	1.57	2.24	2.36	2.25	2.56	2.69	3.16
Invested Capital Turnover	1.31	1.19	0.99	0.95	1.15	0.98	1.04	1.28	1.29	1.21	1.24
Increase / (Decrease) in Invested Capital	0.78	0.15	-0.20	-0.30	0.30	0.99	0.92	0.76	0.98	0.46	0.79
Enterprise Value (EV)	1.16	0.88	2.77	3.68	4.49	1.12	-2.35	0.83	-1.18	1.19	1.25
Market Capitalization	5.45	3.53	8.66	13	12	6.38	6.56	8.83	5.33	6.87	4.99
Book Value per Share	$0.43	$0.30	$0.42	$6.96	$3.72	$3.06	$3.64	$2.24	$1.69	$1.33	$1.08
Tangible Book Value per Share	$0.40	$0.27	$0.40	$6.69	$3.54	$2.87	$3.50	$2.15	$1.59	$1.23	$0.98
Total Capital	5.56	3.90	7.34	11	9.10	7.49	11	10	9.07	8.37	6.90
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-4.29	-2.65	-5.90	-9.44	-7.52	-5.26	-8.91	-8.00	-6.51	-5.68	-3.74
Capital Expenditures (CapEx)	-0.03	0.03	0.00	0.00	0.03	0.04	0.00	0.01	0.02	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.70	0.58	0.90	0.90	0.98	1.62	1.81	1.72	1.88	1.98	2.48
Debt-free Net Working Capital (DFNWC)	4.99	3.23	6.79	10	8.50	6.88	11	9.71	8.39	7.66	6.22
Net Working Capital (NWC)	4.99	3.23	6.79	10	8.50	6.88	11	9.71	8.39	7.66	6.22
Net Nonoperating Expense (NNE)	0.65	0.56	0.57	0.49	0.61	0.45	0.59	0.49	0.12	0.65	0.48
Net Nonoperating Obligations (NNO)	-4.29	-2.65	-5.90	-9.44	-7.52	-5.26	-8.91	-8.00	-6.51	-5.68	-3.74
Total Depreciation and Amortization (D&A)	0.02	0.03	0.13	0.03	0.04	0.03	0.04	0.03	0.03	0.03	0.03
Debt-free, Cash-free Net Working Capital to Revenue	61.16%	41.61%	58.51%	57.65%	59.66%	95.10%	91.72%	71.73%	70.59%	66.42%	72.68%
Debt-free Net Working Capital to Revenue	433.18%	232.01%	443.98%	662.13%	519.45%	403.05%	542.31%	406.03%	315.21%	256.88%	182.38%
Net Working Capital to Revenue	433.18%	232.01%	443.98%	662.13%	519.45%	403.05%	542.31%	406.03%	315.21%	256.88%	182.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($78.00)	($3.00)	($1.87)	($0.99)	($1.42)	($0.72)	($0.66)	($0.38)	($0.47)	($0.37)	($0.26)
Adjusted Weighted Average Basic Shares Outstanding	30.65K	647.61K	1.04M	1.74M	1.50M	2.45M	3.21M	4.87M	3.99M	6.25M	6.41M
Adjusted Diluted Earnings per Share	($78.00)	($3.00)	($1.87)	($0.99)	($1.42)	($0.72)	($0.66)	($0.38)	($0.47)	($0.37)	($0.26)
Adjusted Weighted Average Diluted Shares Outstanding	30.65K	647.61K	1.04M	1.74M	1.50M	2.45M	3.21M	4.87M	3.99M	6.25M	6.41M
Adjusted Basic & Diluted Earnings per Share	($78.00)	$0.00	$0.00	$0.00	($1.42)	$0.00	$0.00	$0.00	($0.47)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	646.68K	875.05K	1.57M	2.44M	2.45M	3.09M	4.57M	5.35M	6.30M	6.40M	8.61M
Normalized Net Operating Profit after Tax (NOPAT)	-1.75	-1.41	-1.38	-1.23	-1.52	-1.33	-1.52	-1.34	-1.75	-1.66	-1.19
Normalized NOPAT Margin	-283.69%	-367.75%	-447.73%	-486.38%	-220.20%	-293.21%	-262.37%	-201.25%	-182.27%	-214.62%	-118.10%
Pre Tax Income Margin	-388.74%	-525.36%	-639.61%	-694.82%	-314.57%	-418.88%	-374.82%	-287.49%	-260.39%	-306.60%	-168.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Innovative Eyewear Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Innovative Eyewear's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Innovative Eyewear's net income appears to be on an upward trend, with a most recent value of -$7.59 million in 2025, rising from -$3.24 million in 2021. The previous period was -$7.77 million in 2024. See where experts think Innovative Eyewear is headed by visiting Innovative Eyewear's forecast page.

Innovative Eyewear's total operating income in 2025 was -$8.49 million, based on the following breakdown:

Total Gross Profit: $567.45 thousand
Total Operating Expenses: $9.06 million

Over the last 4 years, Innovative Eyewear's total revenue changed from $690.67 thousand in 2021 to $2.66 million in 2025, a change of 285.4%.

Innovative Eyewear's total liabilities were at $1.07 million at the end of 2025, a 44.5% increase from 2024, and a 74.1% increase since 2021.

In the past 4 years, Innovative Eyewear's cash and equivalents has ranged from $79.73 thousand in 2021 to $6.51 million in 2025, and is currently $6.51 million as of their latest financial filing in 2025.

Over the last 4 years, Innovative Eyewear's book value per share changed from 0.04 in 2021 to 1.69 in 2025, a change of 4,179.0%.

Related Companies

Financial statements for NASDAQ:LUCY last updated on 8/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innovative Eyewear (LUCY) Financials

Financials Breakdown Chart

Innovative Eyewear Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innovative Eyewear (LUCY) Financials

Annual Income Statements for Innovative Eyewear

Quarterly Income Statements for Innovative Eyewear

Annual Cash Flow Statements for Innovative Eyewear

Quarterly Cash Flow Statements for Innovative Eyewear

Annual Balance Sheets for Innovative Eyewear

Quarterly Balance Sheets for Innovative Eyewear

Annual Metrics And Ratios for Innovative Eyewear

Quarterly Metrics And Ratios for Innovative Eyewear

Financials Breakdown Chart

Innovative Eyewear Financials - Frequently Asked Questions

When does Innovative Eyewear's financial year end?

How has Innovative Eyewear's net income changed over the last 4 years?

What is Innovative Eyewear's operating income?

How has Innovative Eyewear's revenue changed over the last 4 years?

How much debt does Innovative Eyewear have?

How much cash does Innovative Eyewear have?

How has Innovative Eyewear's book value per share changed over the last 4 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools